LONGENECKER JOHN P PHD
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to LONGENECKER JOHN P PHD. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| PCRX | Sale | 7,000 | $71.74 | $502,180 | Mar 3, 2022 | |
| PCRX | Award / Grant | 1,066 | — | — | Jun 9, 2021 | |
| PCRX | Sale | 5,000 | $72.26 | $361,300 | Mar 1, 2021 | |
| PCRX | Award / Grant | 1,260 | — | — | Jun 9, 2020 | |
| PCRX | Option Exercise | 3,736 | $1.61 | $6,015 | Mar 12, 2020 | |
| PCRX | Option Exercise | 872 | $1.61 | $1,404 | Dec 2, 2019 | |
| PCRX | Award / Grant | 4,134 | — | — | Jun 5, 2019 | |
| RNTX | President and CEO | Purchase | 10,000 | $2.45 | $24,500 | Aug 10, 2018 |
| PCRX | Award / Grant | 782 | — | — | Jun 13, 2018 | |
| PCRX | Award / Grant | 1,357 | — | — | Jun 14, 2017 | |
| PCRX | Award / Grant | 1,488 | — | — | Jun 15, 2016 | |
| PCRX | Purchase | 300 | $66.55 | $19,965 | Jan 12, 2016 | |
| PCRX | Award / Grant | 2,000 | — | — | Jun 3, 2015 | |
| PCRX | Option Exercise | 3,000 | $29.90 | $89,700 | Mar 12, 2015 | |
| PCRX | Sale | 1,000 | $93.32 | $93,320 | Dec 29, 2014 | |
| PCRX | Sale | 1,000 | $96.40 | $96,400 | Sep 29, 2014 | |
| PCRX | Option Exercise | 1,000 | $29.90 | $29,900 | Jun 30, 2014 | |
| PCRX | Sale | 1,000 | $64.63 | $64,630 | Mar 28, 2014 | |
| PCRX | Option Exercise | 574 | $1.61 | $924 | Dec 30, 2013 | |
| PCRX | Sale | 2,500 | $46.74 | $116,850 | Sep 30, 2013 | |
| PCRX | Sale | 2,000 | $28.09 | $56,180 | Jun 28, 2013 | |
| PCRX | Sale | 2,000 | $28.49 | $56,980 | Mar 28, 2013 | |
| 0001285701 | President & CEO | Sale | 37,060 | $0.02 | $741 | Dec 11, 2008 |
| 0001285701 | President & CEO | Gift | 6,500 | — | — | May 8, 2008 |